(PRWEB) November 01, 2011
Within the last two weeks the Los Angeles Times, Houston Chronicle and USA Today have published positive features on the many benefits associated with stem cell treatment. As a result, http://www.StemGenex.com, a U.S. based company, is seeing a surge in patient interest. StemGenex provides access to adult stem cell treatment for clients challenged with a variety of chronic medical conditions.
As part of the recent surge in public acceptance of adult stem cell treatment, the Vatican has agreed to donate one million dollars to stem cell research. In addition, a special conference will take place this November in Rome to discuss a world-wide education campaign dedicated specifically to the subject. This breakthrough speaks volumes to the various misconceptions shrouding stem cell therapy and may focus attention on how stem cell treatment can positively impact the quality of life for many people today.
“More than ever, U.S. physicians are supportive of their patients receiving stem cell treatment especially when the stem cells are harvested from the patient without risk of rejection. Their patients' positive responses to stem cell treatment are undeniable,” says Rita Alexander of StemGenex. “Our company is excited the Vatican, presidential candidates, celebrities, and now the mainstream media is recognizing the many people we can help through adult stem cell treatments without having a moral conflict!”
Since the recent outpouring of public support, backed by clinical research, http://www.StemGenex.com has had a stream of client interest. Patients with Multiple Sclerosis, COPD, Parkinson’s and Alzheimer’s disease, auto-immune conditions and even some with diabetes have been contacting the company to learn more about stem cell treatment. As the spotlight brightens on adult stem cell therapy, StemGenex wants the public to understand that their own fat is loaded with adult stem cells and these powerhouse cells have the ability to repair and replace damaged cells. Healthy cells can improve the quality of life for those suffering with a long list of diseases.
“The media has done a great job the last couple of weeks explaining why adult stem cell options are considered safe, non-invasive and non-controversial,” Alexander continued. “However, a lot of the literature didn’t really get into what exactly an adult stem cell is and why it is different from an embryonic stem cell. I think a lot of new clients are turning to StemGenex because our website, http://www.StemGenex.com clearly discusses the facts and offers transparent testimonials.”
StemGenex is one of the industry leaders within the stem cell community. Both the media, and public, are invited to query the company about services offered or to speak with a Patient Advocate directly. As the thought process around stem cell treatment evolves, StemGenex is looking forward to challenging the medical community and media with new discoveries.